Lipoprotein (a) Molarity Assay
K-Number: K253069 · 2026-06-16
Device Summary
Frequently Asked Questions
What is the Lipoprotein (a) Molarity Assay?
Lipoprotein (a) Molarity Assay is a medical device that received FDA 510(k) clearance on 2026-06-16. The listed applicant is Diazyme Laboratories, Inc.. The 510(k) number is K253069.
When did Lipoprotein (a) Molarity Assay receive FDA 510(k) clearance?
Lipoprotein (a) Molarity Assay received FDA 510(k) clearance on 2026-06-16, under 510(k) number K253069.
Who is the listed applicant for Lipoprotein (a) Molarity Assay?
The FDA 510(k) record lists Diazyme Laboratories, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Lipoprotein (a) Molarity Assay?
The FDA product code for Lipoprotein (a) Molarity Assay is DFC.
Other records listing Diazyme Laboratories, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: DFC)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.